Skip to content

Pediatric Integrative Medicine Trial Pilot

Pilot Study of Pediatric Integrative Medicine in Pediatric Oncology, General Pediatrics and Pediatric Cardiology

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02028832
Acronym
PIM
Enrollment
872
Registered
2014-01-07
Start date
2013-02-28
Completion date
2016-09-30
Last updated
2017-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Nausea, Pain, Vomiting

Keywords

pain, nausea/vomiting, anxiety, complementary and alternative medicine, pediatric, oncology, cost-effectiveness

Brief summary

This study will investigate if adding complementary therapies such as acupuncture, massage and reiki to inpatient pediatric care is feasible and what the effects are on outcomes such as patient symptoms, cost, safety, satisfaction and length of stay.

Detailed description

Study Objective: To determine if a pediatric integrative medicine (PIM) service is effective in reducing overall symptoms of pain, nausea/vomiting, and/or anxiety (PNVA), length of stay, and costs, in hospitalized children when compared to conventional care. In this context, integrative refers to a combined approach of complementary and conventional medical therapies in an evidence-based fashion. Design: cluster trial; 2-arm controlled evaluation study in pediatric oncology, general pediatrics and pediatric cardiology. Intervention will be offered during a 6-month PIM period following a 6 month control period. Population: Inclusion criteria: (i) In-patients in participating division and (ii) informed consent/assent. Exclusion criteria: (i) lack of parent participation, fluency in English, or informed consent Intervention: Recommendations for specific CAM therapies will be determined by a staff PIM pediatrician. Any combination of the following CAM therapies (dose, duration, amount to be based on patient need as assessed by CAM provider, patient, and parent): acupuncture/acupressure, massage, Reiki; all are to be offered in addition to usual care. Control: Usual care. Outcomes: Primary outcome: feasibility (i.e enrollment); Secondary outcomes: (i) PNVA symptom management, (ii) need for conventional pharmacotherapy, (iii) adverse events; (iv) parent and health care provider satisfaction with care provided, v) length of stay; and vi) cost-effectiveness (analysis of this outcome to be limited to patients admitted for at least 2 days and for not more than 30 days). Significance: To our knowledge, this study will be the first comparative effectiveness trial to assess the impact of PIM for hospitalized children with cancer.

Interventions

PROCEDUREPIM consult and service provision

If service is requested, treatment options include acupuncture/acupressure, massage, and reiki

PROCEDUREUsual care

Usual care consists of all conventional care options in pediatric oncology including medication and other therapies.

Sponsors

Lotte & John Hecht Memorial Foundation
CollaboratorOTHER
University of Alberta
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 16 Years
Healthy volunteers
No

Inclusion criteria

* (i) all children, aged 0-16 years, who are admitted to Pediatric Oncology, General Pediatrics and Pediatric Cardiology at the Stollery Children's Hospital, Edmonton, Canada who * (ii) can communicate in English; and * (iii) give informed consent/assent

Exclusion criteria

* (i) cannot communicate in English; * (ii) lack of parent availability to participate; or * iii) lack of informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Enrollmentup to 5 daysEnrollment of study participants over length of study which will inform conduct of a larger study in this population

Secondary

MeasureTime frameDescription
Change in painup to 5 daysFor pre-verbal children: Faces, Legs, Activity, Cry, Consolability tool Verbal children: faces Pain Scale-Revised
Change in nausea/vomitingup to 5 daysBaxter Retching Faces scale
Change in anxietyup to 5 daysPediatrics Anxiety Faces scale
Parent satisfaction with patient careup to 5 daysHospital's standardized satisfaction survey; State-Trait Anxiety Invenvtory
Length of hospital stayup to 5 days
Incidence of adverse eventsup to 5 daysBC Children's Hospital Patient Safety Questionnaire; Canadian Pediatric Trigger tool

Other

MeasureTime frameDescription
Resource Utilization/CostAnalysis of this outcome to be limited to patients admitted for at least 2 days and for not more than 30 daysResource utilization and related costs will be compared between study arms

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026